ResearcherKyushu UniversityActive in the last 2 years
Kenjiro Date
Matched on ORCID iD 0000-0003-0376-1000; OpenAlex author ID A5058399474. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 37
2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper
Papers 4
- Patients With Pancreatic Cancer With Synchronous Liver Oligometastasis Show a Significant Long-Term Survival Benefit From Resection Under Specific Conditions: … Co-author DOI 10.1002/jhbp.12181↗
- Conversion surgery for initially unresectable locally advanced pancreatic ductal adenocarcinoma after chemotherapy followed by carbon-ion radiotherapy: a case … Co-author DOI 10.1186/s13256-023-04311-3↗
- Preoperative frailty as a predictive factor for postoperative complications in patients with pancreatic cancer. Co-author DOI 10.18999/nagjms.85.3.518↗
- Surveillance of patients with intraductal papillary mucinous neoplasm with and without pancreatectomy with special reference to the incidence of concomitant pa… Co-author DOI 10.1016/j.surg.2017.09.040↗
Closest collaborators
The 25 strongest of 37 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Kazuyoshi Nishihara · 2 shared papers, 2023–2024 · strength 0.41
- Paper Conversion surgery for initially unresectable locally advanced pancreatic ductal adenocarcinoma after chemotherapy foll… DOI 10.1186/s13256-023-04311-3↗
- Paper Preoperative frailty as a predictive factor for postoperative complications in patients with pancreatic cancer. DOI 10.18999/nagjms.85.3.518↗
- So Nakamura · 2 shared papers, 2018–2023 · strength 0.26
- Paper Preoperative frailty as a predictive factor for postoperative complications in patients with pancreatic cancer. DOI 10.18999/nagjms.85.3.518↗
- Paper Surveillance of patients with intraductal papillary mucinous neoplasm with and without pancreatectomy with special refe… DOI 10.1016/j.surg.2017.09.040↗
- Masafumi Nakamura · 2 shared papers, 2018–2025 · strength 0.25
- Paper Patients With Pancreatic Cancer With Synchronous Liver Oligometastasis Show a Significant Long-Term Survival Benefit Fr… DOI 10.1002/jhbp.12181↗
- Paper Surveillance of patients with intraductal papillary mucinous neoplasm with and without pancreatectomy with special refe… DOI 10.1016/j.surg.2017.09.040↗
- Yoshihiro Miyasaka · 2 shared papers, 2018–2025 · strength 0.25
- Paper Patients With Pancreatic Cancer With Synchronous Liver Oligometastasis Show a Significant Long-Term Survival Benefit Fr… DOI 10.1002/jhbp.12181↗
- Paper Surveillance of patients with intraductal papillary mucinous neoplasm with and without pancreatectomy with special refe… DOI 10.1016/j.surg.2017.09.040↗
- Yusuke Watanabe · 1 shared paper, 2024 · strength 0.23
- Toru Nakano · 1 shared paper, 2024 · strength 0.23
- Tomohiko Shinkawa · 1 shared paper, 2024 · strength 0.23
- Makoto Onji · 1 shared paper, 2023 · strength 0.18
- Koichi Naito · 1 shared paper, 2023 · strength 0.18
- Takeshi Sudo · 1 shared paper, 2025 · strength 0.16
- Hiroaki Nagano · 1 shared paper, 2025 · strength 0.16
- Kenichi Hakamada · 1 shared paper, 2025 · strength 0.16
- Sohei Satoi · 1 shared paper, 2025 · strength 0.16
- Dongha Lee · 1 shared paper, 2025 · strength 0.16
- Masafumi Imamura · 1 shared paper, 2025 · strength 0.16
- Masaaki Hidaka · 1 shared paper, 2025 · strength 0.16
- Teijiro Hirashita · 1 shared paper, 2025 · strength 0.16
- Akihiko Horiguchi · 1 shared paper, 2025 · strength 0.16
- Shugo Mizuno · 1 shared paper, 2025 · strength 0.16
- Shuji Suzuki · 1 shared paper, 2025 · strength 0.16
- Naoto Gotohda · 1 shared paper, 2025 · strength 0.16
- Shigeru Marubashi · 1 shared paper, 2025 · strength 0.16
- Kohei Nakata · 1 shared paper, 2025 · strength 0.16
- Masamichi Mizuma · 1 shared paper, 2025 · strength 0.16
- Hiroshi Kurahara · 1 shared paper, 2025 · strength 0.16
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.